Nonalcoholic fatty liver disease risk in polycystic ovary syndrome patients

Nonalcoholic fatty liver disease risk in polycystic ovary syndrome patients

Saved in:

Bibliographic Details
Main Authors:	Ana M. Fernández-Alonso, Peter Chedraui, Faustino R. Pérez-López
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Gynecological Endocrinology
Online Access:	https://www.tandfonline.com/doi/10.1080/09513590.2024.2359031
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls
by: Justyna Kuliczkowska Plaksej, et al.
Published: (2014-01-01)

Prevalence and factors associated with non-alcoholic fatty liver disease among women with polycystic ovary syndrome
by: Maria Elisa Franciscatto, et al.
Published: (2025-01-01)

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome
by: Susanne Tan, et al.
Published: (2015-01-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
by: Roberto Martínez-Beamonte, et al.
Published: (2020-01-01)

Update on Ppar𝜸 and Nonalcoholic Fatty Liver Disease
by: Gene P. Ables
Published: (2012-01-01)

Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)

Obesity and Polycystic Ovary Syndrome
by: Jin Ju Kim
Published: (2024-12-01)

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease
by: Camelia Cojocariu, et al.
Published: (2020-01-01)

Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome
by: Mohammad Maysara Asfari, et al.
Published: (2020-12-01)

Cardiovascular disease risk prediction by Framingham risk score in women with polycystic ovary syndrome
by: Mina Amiri, et al.
Published: (2025-02-01)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
by: Abdelfattah El Ouaamari, et al.
Published: (2013-01-01)

Serum uric acid and nonalcoholic fatty liver disease
by: Jia Fan, et al.
Published: (2024-11-01)

Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
by: Hannes Hagström, et al.
Published: (2018-01-01)

Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: “Un Affaire de Coeur”
by: Abdulrahman Ismaiel, et al.
Published: (2020-01-01)

Diagnosis and treatment of polycystic ovary syndrome
by: Ronelsys Martínez Martínez, et al.
Published: (2023-11-01)

Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01)

Nonalcoholic Fatty Liver Disease in Patients Investigated for Elevated Liver Enzymes
by: Krikor Kichian, et al.
Published: (2003-01-01)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
by: Xu Boqun, et al.
Published: (2013-01-01)

Maternal polycystic ovary syndrome and Offspring’s Risk of Cardiovascular diseases in Childhood and Young Adulthood
by: Fen Yang, et al.
Published: (2024-11-01)

The Utility of Xenon-133 Liver Scan in the Diagnosis and Management of Nonalcoholic Fatty Liver Disease
by: Said A Al-Busafi, et al.
Published: (2012-01-01)

Relationship of the Degree of Sarcopenia with the Severity of Nonalcoholic Fatty Liver Disease and Cardiometabolic Risk in Adolescents
by: Yoowon Kwon, et al.
Published: (2024-11-01)

Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
by: Ga Eun Nam, et al.
Published: (2018-01-01)

ANTIOXIDANTS AS POTENTIAL BIOMARKERS OF NONALCOHOLIC FATTY LIVER DISEASE STAGES
by: Sofya D. Kravchenko, et al.
Published: (2023-12-01)

Nonalcoholic Fatty Liver Disease: A Clinical Approach and Review
by: Maitreyi Raman, et al.
Published: (2006-01-01)

Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children
by: Anna Alisi, et al.
Published: (2011-01-01)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Elena Buzzetti, et al.
Published: (2015-01-01)

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
by: Ana-Maria Singeap, et al.
Published: (2021-01-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
by: Elena Paschetta, et al.
Published: (2015-01-01)

New biomarkers for diagnosis of polycystic ovary syndrome
by: Farid I. Hassan, et al.
Published: (2023-04-01)

Impact of headache in women with polycystic ovary syndrome
by: Lina Zabulienë, et al.
Published: (2021-12-01)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
by: Pascal Froment, et al.
Published: (2006-01-01)

Polycystic Ovary Syndrome May Be an Autoimmune Disorder
by: Hifsa Mobeen, et al.
Published: (2016-01-01)

Bariatric Surgery, Polycystic Ovary Syndrome, and Infertility
by: James Butterworth, et al.
Published: (2016-01-01)

Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Jung-Hwan Baek, et al.
Published: (2024-10-01)

Insulin Resistance Markers to Detect Nonalcoholic Fatty Liver Disease in a Male Hispanic Population
by: Maritza Pérez-Mayorga, et al.
Published: (2022-01-01)

The Combined Effect of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome on Osteoporosis in Postmenopausal Females in Eastern China
by: Da-Zhi Chen, et al.
Published: (2018-01-01)

Mechanisms and therapeutic implications of selective autophagy in nonalcoholic fatty liver disease
by: Suwei Jin, et al.
Published: (2025-01-01)

Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats
by: Şule Demir, et al.
Published: (2016-01-01)